Thyroid cell apoptosis: A new understanding of thyroid autoimmunity

Endocrinology and Metabolism Clinics of North America

Volumn 29, Issue 2, 2000, Pages 375-388

  Phelps, Ellen ^a   Wu, Peiqing ^a   Bretz, James ^a   Baker Jr , James R ^a,b  

^a Department of Internal Medicine   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 9; CYTOCHROME C OXIDASE; FAS ANTIGEN; FAS LIGAND; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; THYROGLOBULIN ANTIBODY; THYROID HORMONE; THYROID PEROXIDASE; THYROTROPIN RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; CELL DAMAGE; CYTOTOXIC T LYMPHOCYTE; GAMMA IRRADIATION; GRAVES DISEASE; HASHIMOTO DISEASE; HOMEOSTASIS; HUMAN; IMMUNOREGULATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW;

EID: 0034049928     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(05)70137-7     Document Type: Article

References (115)

1. J. Adams S. Cory The Bcl-2 protein family: Arbiters of cell survival Science 281 1998 1322
2. L. Aravind V. Dixit E. Koonin The domains of death: Evolution of the apoptosis machinery Trends Biochem Sci 24 1999 47
3. M.J. Arends A.H. Willie Apoptosis: Mechanisms and roles in pathology Int Rev Exp Pathol 32 1991 223
4. P. Arscott J.R. Baker Jr Apoptosis and thyroiditis Clin Immunol Immunopathol 87 1998 207
5. P. Arscott J. Knapp M. Rymaszewski Fas (APO-1/CD95)-mediated apoptosis in thyroid cells is regulated by a labile protein inhibitor Endocrinology 138 1997 5109
6. J.R. Baker Jr The immune response to papillary thyroid cancer J Clin Endocrinol Metab 80 1995 3419
7. J.R. Baker Jr Autoimmune endocrine disease JAMA 278 1997 1931
8. J.R. Baker Jr C.K. Fosso Immunological aspects of cancers arising from thyroid follicular cells Endocr Rev 14 1993 729
9. D. Bellgrau D. Gold H. Selawry A role for CD95 ligand in preventing graft rejection Nature 377 1995 630
10. M. Bermann M. Magee R. Koenig Differential autoantibody responses to thyroid peroxidase in patients with Graves' disease and Hashimoto's thyroiditis J Clin Endocrinol Metab 77 1993 1098
11. J. Bertin R.C. Armstrong S. Ottile Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-mediated induced apoptosis Proc Natl Acad Sci USA 94 1997 1172
12. U. Bogner B. Sigle H. Scheleusener Interferon-gamma protects human thyroid epithelial cells against cell-mediated cytotoxicity Immunobiology 176 4-5 1988 423
13. M.P. Boldin T.M. Goncharov Y.Y. Goltsev Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/AOP-I and TNF receptor-induced cell death Cell 85 1996 803
14. K. Borgerson J. Bretz J.R. Baker Jr The role of Fas-mediated apoptosis in thyroid autoimmune disease Autoimmunity 30 1999 251
15. J. Bretz P. Arscott A. Myc Inflammatory cytokine regulation of Fas-mediated apoptosis in thyroid follicular cells J Biol Chem 274 1999 25433
16. J. Bretz M. Rymaszewski P. Arscott TRAIL death pathway induction in thyroid follicular cells J Biol Chem 274 1999 23627
17. T. Brunner R.J. Mogil D. LaFace Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas Nature 373 1995 441
18. F. Cecconi G. Alvarez-Bolado B.I. Meyer Apaf-1 (CED-4 homolog) regulates programmed cell death in mammalian development Cell 94 1998 727
19. A. Chervonsky Y. Wang F. Wong The role of Fas in autoimmune diabetes Cell 89 1997 17
20. A.M. Chinnaiyan K. O'Rourke B. Lane Interaction of CED-4 with CED-3 and CED-9: A molecular framework for cell death Science 275 5303 1997 1122
21. A.M. Chinnaiyan K. O'Rourke M. Tewari FADD, a novel death domain-containing protein interacts with the death domain of Fas and initiates apoptosis Cell 81 1995 505
22. V.K. Chiu C.M. Walsh C. Liu Bcl-2 blocks degranulation but not fas-based cell mediated cytotoxicity J Immunol 154 1995 2023
23. P. Cohen R. Eisenberg Lpr and gld: Single gene models of systemic autoimmunity and lymphoproliferative disease Annu Rev Immunol 9 1991 243
24. T. Davies The pathogenesis of Graves' disease L. Braverman R. Utiger Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text ed 7 1996 Lippincott-Raven Philadelphia 525
25. R. De Maria R. Testi Fas-FasL interactions: A common pathogenic mechanism in organ-specific autoimmunity Immunol Today 19 1998 121
26. G.F. Del Prete D. Vercelli A. Tiri In vivo activated cytotoxic T cells in the thyroid infiltrate of patients with Hashimoto's thyroiditis Clin Exp Immunol 65 1986 140
27. J. Dhein H. Walczak C. Baumler Autocrine T-cell suicide mediated by Apo-1/(Fas/CD95) Nature 373 1995 438
28. J. Drappa A.K. Vaishnaw K.E. Sullivan Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative syndrome and autoimmunity Science 268 1995 1347
29. S. Dremier J. Golstein R. Mosselmans Apoptosis in dog thyroid cells Biochem Biophys Res Commun 200 1994 52
30. C.S. Duckett V.E. Nava R.W. Gedrich A conserved family of cellular genes related to the baculovirus iap gene and encoding apoptosis inhibitors EMBO J 15 1996 2685
31. Duke R. Ojcius D. Young J.D. Cell suicide in health and disease Sci Am December 1996 80
32. G.H. Fisher F.J. Rosenberg S.E. Straus Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome Cell 81 1995 935
33. L.E. French M. Hahne I. Viard Fas and Fas ligand in embryos and adult mice: Ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover J Cell Biol 133 1996 335
34. C. Giordano G. Stassi R. De Maria Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis Science 275 1997 960
35. P. Golstein Cell death: TRAIL and its receptors Curr Biol 7 1997 R750
36. D.R. Green Apoptotic pathways: The roads to ruin Cell 94 1998 695
37. D.R. Green J.C. Reed Mitochondria and apoptosis Science 281 1998 1309
38. T.S. Griffith T. Brunner S.M. Fletcher Fas ligand-induced apoptosis as a mechanism of immune privilege Science 270 1995 1189
39. T.S. Griffith D.H. Lynch TRAIL: A molecule with multiple receptors and control mechanisms Curr Opin Immunol 10 1998 559
40. T.S. Griffith X. Yu J.M. Herndon CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance Immunity 5 1996 7
41. L.J. Hammond M.W. Lowdell P.G. Cerrano Analysis of apoptosis in relation of tissue destruction associated with Hashimoto's autoimmune thyroiditis J Pathol 182 1997 138
42. D. Hockenbery G. Nunez C. Milliman Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death Nature 348 6299 1990 334
43. H. Hsu X. Xiong D.V. Goeddel The TNF receptor-1 associated protein TRADD signals death and NF-kappa B activation Cell 81 1995 495
44. S. Hu C. Vincenz M. Buller A novel family of viral death effector domain-containing molecules that inhibit both CD95- and tumor necrosis factor receptor-1–induced apoptosis J Biol Chem 272 1997 9621
45. S. Hu C. Vincenz J. Ni I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1- and CD95-induced apoptosis J Biol Chem 272 1997 17255
46. M. Irmler M. Thome M. Hahne Inhibition of death receptor signals by cellular FLIP Nature 388 6638 1997 190
47. N. Itoh S. Nagata A novel protein domain required for apoptosis: Mutational analysis of human Fas antigen J Biol Chem 268 1993 10932
48. N. Itoh Y. Tsujimoto S. Nagata Effect of bcl-2 on Fas antigen-mediated cell death J Immunol 151 1993 621
49. N. Itoh S. Yonehara A. Ishii The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis Cell 66 1991 233
50. I. Jeremias I. Herr T. Boehler TRAIL/Apo-2-ligand–induced apoptosis in human T cells Eur J Immunol 28 1998 143
51. S.T. Ju D.J. Panka H. Cui Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation Nature 373 1995 444
52. D. Kagi F. Vignaux B. Ledermann Fas and perforin pathways as major mechanisms of T cell–mediated cytotoxicity Science 265 1994 528
53. P.D. Katsikis M.E. Garcia-Ojeda J.F. Torres-Roca Interleukin-1 beta converting enzyme-like protease involvement in Fas-induced and activation-induced peripheral blood T cell apoptosis in HIV infection: TNF-related apoptosis-inducing ligand can mediate activation-induced T cell death in HIV infection J Exp Med 186 1997 1365
54. A. Kawahara T. Kobayashi S. Nagata Inhibition of Fas-induced apoptosis by Bcl-2 Oncogene 17 1998 2549
55. A. Kawakami N. Eguchi N. Matsuoka Modulation of Fas-mediated apoptosis of human thyroid epithelial cells by IgG from patients with Graves' disease (GD) and idiopathic myxoedema Clin Exp Immunol 110 1997 434
56. A. Kawakami K. Eguchi N. Matsuoka Thyroid-stimulating hormone inhibits Fas antigen-mediated apoptosis of human thyrocytes in vitro Endocrinology 137 1996 3163
57. + T cell–mediated cytotoxicity J Immunol 162 1999 2639
58. J.F. Kerr B. Harmon J. Searle An electron-microscope study of cell deletion in the anuran tadpole tail during spontaneous metamorphosis with special reference to apoptosis of striated muscle fibers J Cell Sci 14 1974 571
59. F. Kischkel S. Hellbardt I. Behrmann Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor EMBO J 14 1995 5579
60. R. Kluck E. Bossy-Wetzel D. Green The release of cytochrome c from the mitochondria: A primary site of Bcl-2 regulation of apoptosis Science 275 1997 1132
61. T. Kotani Y. Aratake K. Hirai Apoptosis in thyroid tissue from patients with Hashimoto's thyroiditis Autoimmunity 20 1995 231
62. P. Liston N. Roy K. Tamai Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes Nature 379 1996 349
63. X. Liu C.N. Kim J. Yang Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c Cell 86 1996 147
64. B. Lowin M. Hahne C. Mattmann Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways Nature 370 1994 650
65. W.A. MacKenzie A.E. Schwartz E.W. Friedman Intrathyroidal T cell clones from patients with autoimmune thyroid disease J Clin Endocrinol Metab 64 1987 818
66. M.Y. Mapara R. Bargou C. Sugck APO-1-mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: Correlation with bcl-2 oncogene expression Eur J Immunol 23 1993 702
67. S.A. Marsters R.M. Pitti C.J. Donahue Activation of apoptosis by Apo-2 ligand is independent of FADD but blocked by CrmA Curr Biol 6 1996 750
68. S.A. Marsters J.P. Sheridan C.J. Donahue Apo-3, a new member of the tumor necrosis factor receptor superfamily, contains a death domain and activates apoptosis and NF-kappaB Curr Biol 6 1996 1669
69. S.A. Marsters J.P. Sheridan R.M. Pitti A novel receptor for Apo2L/TRAIL contains a truncated death domain Curr Biol 7 1997 1003
70. S.A. Marsters J.P. Sheridan R.M. Pitti Identification of a ligand for the death-domain–containing receptor Apo3 Curr Biol 8 1998 525
71. S. Matsubayashi K. Kawai Y. Matsumoto The correlation between papillary thyroid carcinoma and lymphocytic infiltration in the thyroid gland [see comments] J Clin Endocrinol Metab 80 1995 3421
72. B. McIver J.C. Morris The pathogenesis of Graves' disease Endocrinol Metab Clin North Am 27 1998 73
73. S. Mihara N. Suzuki S. Wakisaka Effects of thyroid hormones on apoptotic cell death of human lymphocytes J Clin Endocrinol Metab 84 1999 1378
74. N. Mitsiades V. Poulaki V. Kotoula Fas/Fas ligand up-regulation and Bcl-2 down-regulation may be significant in the pathogenesis of Hashimoto's thyroiditis J Clin Endocrinol Metab 83 1998 2199
75. J.D. Mountz J. Wu I. Cheng Autoimmune disease: A problem of defective apoptosis Arthritis Rheum 37 1994 1415
76. M. Muzio A. Chinnaiyan F. Kischkel FLICE, a novel FADD-homologous ICE/CED-3–like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex Cell 85 1996 817
77. A. Myc P. Arscott J. Bretz Characterization of FAP-1 expression and function in thyroid follicular cells Endocrinology 140 1999 5431
78. S. Nagata Apoptosis by death factor Cell 88 1997 355
79. K. Newton A. Strasser The Bcl-2 family and cell death regulation Curr Opin Genet Dev 8 1998 68
80. L.B. Owen-Schaub R. Radinsky E. Kruzel Anti-Fas on nonhematopoietic tumors: Levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness Cancer Res 54 1994 1580
81. G. Pan J. Ni Y.F. Wei TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling FEBS Lett 424 1-2 1998 41
82. G. Pan J. Ni Y.F. Wei An antagonist decoy receptor and a death domain-containing receptor for TRAIL Science 277 1997 815
83. G. Pan K. O'Rourke A.M. Chinnaiyan The receptor for the cytotoxic ligand TRAIL Science 276 5309 1997 111
84. G. Pan K. O'Rourke M. Dixit Caspase-9, Bcl-XL, and Apaf-1 form a ternary complex J Biol Chem 273 1998 5841
85. R.M. Pitti S.A. Marsters D.A. Lawrence Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer Nature 396 6712 1998 699
86. R.M. Pitti S.A. Marsters S. Ruppert Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family J Biol Chem 271 1996 12687
87. C.A. Ray R.A. Black S.R. Kronheim Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1 beta converting enzyme Cell 69 1992 597
88. F. Rieux-Laucat F. Le Deist C. Hivroz Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity Science 268 1995 1347
89. G.S. Salvesen V.M. Dixit Caspases: Intracellular signaling by proteolysis Cell 91 1997 443
90. T. Sato S. Irie S. Kitada FAP-1: A protein tyrosine phosphatase that associates with Fas Science 268 1995 411
91. K. Schulze-Osthoff D. Ferrari M. Los Apoptosis signaling by death receptors Eur J Biochem 254 1998 439
92. J. Sheridan S. Marsters R. Pitti Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors Science 277 1997 818
93. G. Singer A. Abbas The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T Cell receptor transgenic mice Immunity 1 1994 365
94. A. Singh J. Ni B. Aggarwal Death domain receptors and their role in cell demise J Interferon Cytokine Res 18 1998 439
95. D. Smith S. Sieg D. Kaplan Aberrant detection of cell surface Fas ligand with anti-peptide antibodies J Immunol 160 1998 4159
96. G. Stassi M. Todaro F. Bucchieri Fas/Fas ligand-driven T cell apoptosis as a consequence of ineffective thyroid immunoprivilege in Hashimoto's thyroiditis J Immunol 162 1999 263
97. T. Stokes M. Rymaszewski P. Arscott Constitutive expression of FasL in thyrocytes Science 279 1998 2015a
98. A. Strasser A.W. Harris S. Cory bcl-2 Transgene inhibits T cell death and perturbs thymic self censorship Cell 67 1991 889
99. A. Strasser A.W. Harris D.C. Huang Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocytes apoptosis EMBO J 14 1995 6136
100. A. Strasser A.W. Harris H. von Boehmer Positive and negative selection of T cells in T-cell receptor transgenic mice expressing a bcl-2 transgene Proc Natl Acad Sci USA 91 1994 1376
101. S.A. Susin N. Zamzami M. Castedo Bcl-2 inhibits the mitochondrial release of an apoptotic protease J Exp Med 184 1996 1331
102. C. Tanimoto S. Hirakawa H. Kawasaki Apoptosis in thyroid diseases: A histochemical study Endocr J 42 1995 193
103. L.A. Tartaglia T.M. Ayres G.H. Wong A novel domain within the 55 kd TNF receptor signals cell death Cell 74 1993 845
104. C.B. Thompson Apoptosis in the pathogenesis and treatment of disease Science 267 1995 1456
105. N. Thornberry Y. Lazebnik Caspases: Enemies within Science 281 1998 1312
106. A. Uren M. Pakusch C. Hawkins Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors Proc Natl Acad Sci USA 93 1996 4974
107. R. Watanabe-Fukunaga C. Brannan N. Copeland Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis Nature 356 1992 314
108. A.P. Weetman A.M. McGregor Autoimmune thyroid disease: Developments in our understanding Endocr Rev 10 1989 537
109. A.P. Weetman A.M. McGregor Autoimmune thyroid disease: Developments in our understanding Endocr Rev 15 1994 788
110. A.H. Wyllie Glucocorticoinduced thymocyte apoptosis is associated with endogenous endonuclease activation Nature 284 1980 555
111. J. Wu J. Wilson J. He Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease J Clin Invest 98 1996 1107
112. Wu P, Baker JR Jr: Apoptosis in autoimmune thyroid disease. In press
113. W. Xerri E. Devilard J. Hassoun Fas ligand is not only expressed in immune privileged human organs but it is also coexpressed with Fas in various epithelial tissues Mol Pathol 50 1997 87
114. A. Zeytun M. Hassuneh M. Nagarkatti Fas-Fas ligand-based interactions between tumor cells and tumor-specific cytotoxic T lymphocytes: A lethal two-way street Blood 90 1997 1952
115. H. Zou Y. Li X. Liu An Apaf-1-cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9 J Biol Chem 274 1999 11549